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Edited by Paul BertoneAbstract The high-mobility group (HMG) protein A2 has been
studied mostly in the mouse where its function seems critical for
embryonic cell growth and adipogenesis, leading to a pygmy phe-
notype with greatly reduced fat tissue in homozygous knock out
mice. We showed recently that among the major HMG proteins,
HMGA2 is highly expressed in two human embryonic stem
(hES) cell lines. Here, we employed siRNA technology in combi-
nation with quantitative reverse transcriptase polymerase chain
reaction, stem cell-speciﬁc microarray analyses, and cell prolif-
eration assays in order to probe into HMGA2’s role(s) in plurip-
otent hES cells. Our results establish HMGA2 as a regulator of
human genes linked to mesenchymal cell diﬀerentiation, adipo-
genesis, and hES cell growth.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
Keywords: High-mobility group protein; DNA architectural
protein; Human embryonic stem cells; Cell proliferation;
Cell diﬀerentiation1. Introduction
Mammalian high-mobility group AT-hook (HMGA) pro-
teins are encoded by two genes, HMGA1 and HMGA2. Both
proteins are characterized by an acidic C-terminal tail and
the presence of three individual DNA binding domains, the
so-called AT-hooks, which bind short stretches of AT-rich
DNA with high aﬃnity [1]. HMGA2 has been studied in detail
in the mouse where it is expressed in pluripotent embryonic
stem (ES) cells and during embryogenesis, but is absent or
present at low levels in adult tissues. Its function seems critical
for cell growth and adipogenesis because mice lacking func-
tional HMGA2 exhibit a pygmy phenotype with greatly re-
duced fat tissue [2]. In addition, over-expression of a
truncated HMGA2 protein lacking the C-terminal tail resulted
in gigantism and lipomatosis [3]. However, very little is knownAbbreviations: qRT-PCR; quantitative reverse transcriptase polymer-
ase chain reaction
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doi:10.1016/j.febslet.2007.06.072about the underlying molecular mechanism(s) which lead to
the development of these phenotypes.
In humans, high HMGA2 protein levels are associated with
most malignant neoplasias, and HMGA2 rearrangements are
frequently found in benign tumors of mesenchymal origin
[4,5]. Interestingly, a germ-line truncatedHMGA2 gene was re-
cently found to be associated with a case of extreme somatic
overgrowth and multiple lipomas, thus also linking HMGA2
to general cell growth and adipogenesis during human devel-
opment [6]. Furthermore, recent data hint at novel roles for
HMGA2 in heterochromatin formation in cultured human
cells and in the epithelial–mesenchymal transition during
embryogenesis and metastasis [7,8].
Recently, we demonstrated that HMGA2 is expressed at a
high level in pluripotent human embryonic stem (hES) cells
[9]. We also showed that HMGA2 is further up-regulated dur-
ing a short time window in very early stages of hES cell diﬀer-
entiation ex vivo. Furthermore, our data supported the
possibility that HMGA2 interacts with nucleosomes in a way
that might contribute to a speciﬁc state of chromatin domains
which, in turn, may be critical for the establishment of both
hES cell identity and the regulation of diﬀerentiation programs.
Therefore, to further elucidate the biological function(s) of
HMGA2 in hES cells, we investigated here the eﬀects of small
interfering (si)RNA-mediated knock-down of HMGA2 on
the expression of 930 stem cell-speciﬁc genes and selected prom-
inent diﬀerentiation/pluripotency markers using a stem cell-
speciﬁc microarray platform and qRT-PCR, respectively. We
also demonstrate directly, through siRNA technology, that
HMGA2 is critically involved in the regulation of hES cells pro-
liferation through a pathway that possibly employs undiﬀeren-
tiated transcription factor1 (UTF1).2. Materials and methods
2.1. Cell culture
We employed in this study karyotypical normal hES cell lines
HUES-7 (46XY) and HUES-8 (46 XY) [10]. Cells were cultured on
inactivated murine embryonic ﬁbroblasts (MEFs) as previously de-
scribed [9,11]. MEFs contribute about 10% cells at the time of hES cell
harvest.
2.2. SiRNA treatment
About 1 · 105 HUES-8 cells were seeded per well (24-well plate) on
MEFs at day 0, and incubated with 0.5 ml of antibiotic-free media con-
taining 200 nM HMGA2- speciﬁc siRNA (Dharmacon Corp.) plus
4 l1 of DharmaFECT2 transfection reagent (Dharmacon Corp.) forblished by Elsevier B.V. All rights reserved.
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were harvested on day 3, and processed for qRT-PCR and Western
blot analysis. The same protocol was applied also using transfection re-
agent only (denoted as mock) or 200 nM non-target (nt)-siRNA
(Dharmacon Inc.) for microarray analyses (see Section 2.5).
2.3. Western blot analysis
Harvested cells were lysed in NP40 buﬀer containing 1% SDS. Ly-
sates were sonicated on ice (5 W; 10 · 3 s). Protein concentrations were
determined with the BCA protein Assay Kit (Pierce Biotechnology,
Rockford, IL) according to manufacturer’s instructions. Lysates equiv-
alent to 15 lg of total protein (about 1 · 105 cells) were resolved
through 15% SDS–PAGE and subsequently transferred to PVDF
membrane with 20 lm pore size (Bio-Rad). The blot was blocked with
5% nonfat milk and incubated with goat polyclonal antibodies against
HMGA2 (S15, Santa Cruz Biotechnology, CA), using a 1:500 dilution.
Bound antibodies were detected by secondary anti-goat HRP-conju-
gated antibodies (Santa Cruz Biotechnology) and Lumi-light Western
blotting substrate (Roche Diagnostic GmbH, Mannheim, Germany).
b-actin was probed as an internal control, using monoclonal antibodies
raised against human b-actin (Sigma). The Western blot was scanned
using Molecular Imager FX (Bio-Rad) and band intensities were quan-
tiﬁed by Quantity One (Bio-Rad).
2.4. Copy-DNA synthesis and quantitative RT-PCR
We routinely used 500 ng of puriﬁed total RNA (Qiagen GmbH,
Germany) from each sample, which was reverse-transcribed using
SuperScript First Strand Synthesis Kit for RT-PCR (Invitrogen, Carls-
bad, CA). 1 l1 of the ﬁnal 21 l1 reaction served as template for quan-
titative PCR using QuantiTech SYBR Green PCR Kit (Qiagen) and
the primers listed in the Supplementary Data link at: http://vhp.ntu.e-
du.sg/hmga2/pd.htm. Reactions were run in triplicate on an ABI 7500
real-time PCR System (Applied Biosystem, Forster City, CA) and were
analyzed with the SDS1.2 program (Applied Biosystem). The identity
of PCR products was always conﬁrmed by agarose gel electrophoresis.
2.5. Microarray analysis
Transfection protocols were described under Section 2.2. Mock-,
non-target (nt)- siRNA- and HMGA2-speciﬁc siRNA-treated hES
cells were subjected to the PIQOR Stem Cell Microarray platform
(Miltenyi Biotech GmbH, Germany; http://www.miltenyibiotec.com),
using, in each case, untreated hES cells as reference. Total RNA was
isolated via standard RNA extraction protocols (Macherey & Nagel,
NucleoSpin RNA). RNA samples were quality checked using the Agi-
lent 2100 Bioanalyzer platform (Agilent Technologies, Palo Alto,
USA). RNA from each sample (0.5 lg) was then used for linear ampli-
ﬁcation, and subsequently checked again via the Agilent 2100 plat-
form. For each of the three sample pairs, i.e. mock against untreated
hES cells, (nt)-siRNA against untreated hES cells, and siRNA against
untreated hES cells, duplicate microarray analyses were conducted.
The slides were scanned using a ScanArray Lite laser scanner (Per-
kin–Elmer Life Sciences, Boston, USA), and images were analyzed
using ImaGene@ software (BioDiscovery Inc., EI Segundo, USA).
The two-channel raw signal intensities were background correctedTable 1
Top 10 diﬀerentially expressed genes in hES cells after HMGA2 knock-dow
ID NAME ACC U
25938 HMGA2 P52926 H
29198 LEFTB_HUMAN O75610 H
20559 SEMA6A1 Q9P2H9 H
29197 LEFTA_HUMAN O75611 H
2035 CALB1 P05937 H
2277 COL16A1 Q07092 H
15918 POU5F1 Q9BZV9 H
812 GJA1_1 P17302 H
32488 NPM1 P06748 H
2309 COL6A2_1 P12110 H
The table columns are: ID: Gene ID; NAME: Gene Name; ACC: SwissProt/T
Expression fold change between (siRNA vs. mock and ntsiRNA); adj. P: adju
testing using Benjamini–Hochberg method); B: B-statistics of empirical Bayand normalized using the LOESS ﬁtting method [12], implemented
in the Bioconductor package LIMMA [13]. An empirical Bayes mod-
erated t-test [13,14] was applied to call diﬀerentially expressed genes
across the siRNA samples and the other two samples. P-values were
corrected for multiple testing using Benjamini–Hochberg (BH) method
[15]. Genes with an adjusted P-value <0.05 were selected as diﬀeren-
tially expressed ones. There were 14 genes meeting these criteria, and
the top 10 exhibit P-values <0.025 (Table 1). The complete list of
two-channel raw signal intensities and channel ratios of all genes,
and information such as log-ratios, P-values, adjusted P-values, t-sta-
tistics and B-statistics of the selected genes can be retrieved from Sup-
plementary Data at http://vhp.ntu.edu.sg/hmga2/pd.htm.
2.6. Proliferation assay
3 · 104 hES cells were seeded in MEF-layered 96 well plates at day 0.
On day 1, cells were incubated with 0.2 ml of antibiotic-free media con-
taining 200 nM HMGA2- speciﬁc siRNA plus 1.6 l1 of Dharma-
FECT2 reagent (Dharmacon Corp.) for 24 h. This was repeated on
days 2 and 3. WST-1 (Roche) was added to the media at a ﬁnal con-
centration of 10% on days 1–4, and plates were incubated at 37 C
for 30 min. At 24 h intervals, absorbance (440 nm) was recorded by
a standard photoplate reader, using media (cell-free) as reference.
The assay was performed in triplicates with (nt)-siRNA as controls.3. Results and discussion
3.1. siRNA-mediated down-regulation of HMGA2 in hES cells
We employed siRNA technology in this study to probe into
HMGA2’s biological role(s) in pluripotent hES cells and veri-
ﬁed ﬁrst that transfection of HMGA2-speciﬁc siRNAs signiﬁ-
cantly reduced the level of HMGA2 protein. Using Western
blot analyses, we demonstrate that repeated siRNA transfec-
tions over a period of 72 h reproducibly led a 4- to 5-fold de-
crease when compared with un-transfected, mock transfected,
or non-target (nt)-siRNA transfected hES cells (Fig. 1). These
results are consistent with the eﬃcacy of siRNA-mediated
knock-down seen in qRT-PCR analyses where the level of
HMGA2 mRNA was reduced about 7-fold (Fig. 2).
3.2. HMGA2 aﬀects the expression of key pluripotency and
diﬀerentiation markers
Having established that our siRNA protocol signiﬁcantly re-
duced HMGA2 protein levels in HUES8 cells during a period
of 72 h, we employed qRT-PCR to determine changes in
mRNA levels of a selected set of well-known key pluripotency
and diﬀerentiation markers, using mock- and nt-siRNA-trea-
ted hES cells as reference. The results show that the mRNA
level of human undiﬀerentiated transcription factor 1 (hUTF1)n
niGene FC adj. P B
s.2726 0.472 0 13.795
s.278239 1.745 0 5.698
s.263395 0.735 0.011 2.315
s.25195 1.495 0.015 1.682
s.65425 0.69 0.015 1.502
s.26208 1.565 0.015 1.274
s.2860 0.759 0.015 1.236
s.74471 0.674 0.021 0.813
s.411098 0.796 0.023 0.61
s.420269 1.414 0.024 0.466
rEMBL accession number; UniGene: UniGene Accession number; FC:
sted P-value of empirical Bayes moderated t-test (corrected for multiple
es moderated t-test.
Fig. 1. Western analysis of HMGA2 protein expression upon siRNA
treatment using b-actin as internal reference. Quantiﬁcation of the
Western analysis was obtained using HMGA2 expression in untreated
HUES-8 cells as 100%.
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pluripotency genes OCT3/4, NANOG, and SOX2 remained
nearly unaﬀected (Fig. 2). UTF1 is one of the most sensitive
pluripotency markers known for ES cells and is quickly down-
regulated at the onset of diﬀerentiation [16]. It encodes for a
transcription factor that interacts with ATF2; however, the
downstream target genes have not been identiﬁed. Interest-
ingly, UTF1 was recently found to be involved in the control
of ES cell proliferation in the mouse [17]. Hence, our results
suggest a link between HMGA2, cell proliferation control,
and pluripotency in hES cells (see below).
We also analyzed mRNA levels of well-known markers for
all 3 germ layers and found that down-regulation of HMGA2
reduced the transcript level for the mesoderm marker gene
insulin like growth factor 2 (IGF2) and for the neural stem cell
speciﬁc marker NESTIN. In contrast, knock-down of
HMGA2 signiﬁcantly increased the levels of transcripts coding
for endoderm markers SOX17 and MIXL1 (Fig. 2). These
ﬁndings suggest that HMGA2 plays a role in maintaining a
balance of mesodermal versus endodermal cell diﬀerentiation
in hES cells. Interestingly, in addition to IGF2’s role in meso-Fig. 2. DD analysis of quantitative RT-PCR test on the expression levels
hGAPDH as internal reference. Each reaction was carried out in triplicate and
transfected cells to the average DRn in both mock and (nt)-siRNA transfectdermal cell lineage commitment, it has also been associated
with human fetal growth [18], which, again, links HMGA2
with cell proliferation during embryogenesis.
3.3. HMGA2 is a co-regulator of genes linked to mesenchymal
cell diﬀerentiation and adipogenesis in hES cells
We next employed siRNA in combination with the PI-
QOR Stem Cell Microarray platform, which contains anti-
sense probes for 930 selected, stem cell-speciﬁc genes. Applying
stringent selection criteria (see Section 2.5, for details), our
data analysis revealed that 14 genes, including HMGA2, were
diﬀerentially expressed at a signiﬁcant level. The top 10 genes
are listed in Table 1. Importantly, the results conﬁrmed again
that siRNA treatment signiﬁcantly decreased the level of our
target HMGA2 mRNA.
Among the remaining nine genes listed in Table 1, 3 code for
proteins well known to play an important role in embryogen-
esis. Expression of LEFTY genes, LEFTYA and LEFTYB was
increased. These genes are transiently expressed during early
hES cell diﬀerentiation in embryoid bodies. They are known
to be controlled by the NODAL signaling pathway, and their
expression appears to play a substantial role in mesodermal
cell lineage establishment [19]. They are also involved in the
left-right body symmetry formation and control of gastrula-
tion. Interestingly, both genes are located on human chromo-
some #1 as direct repeats and separated by only 50 kb. It is
tempting to speculate, therefore, that HMGA2 as DNA archi-
tectural factor might be a constituent of the corresponding
chromatin domain that harbors the control regions for LEFTY
genes and, as such, contributes to their regulation in hES cells.
The expression of the third gene, semaphorin 6A-1, was de-
creased upon siRNA treatment. This gene belongs to a group
of genes coding for proteins that are guidance signals in
embryogenesis [20].
It is probably noteworthy that another prominent cell diﬀer-
entiation marker that did not pass our stringent selection crite-
ria, but still ranks at position 53 in our list of 930 genes, is
DLK1. Its expression increased (1.22 fold change) as a result
of HMGA2 knockdown. The encoded protein, also known
as preadipocyte factor 1, contains EGF-like repeats and,of puripotency and germ-line markers upon siRNA treatment using
the value was obtained by comparing DRn in HMGA2-speciﬁc siRNA
ed cells. Error bar represents the standard deviation of the triplicate.
Fig. 3. ES cell proliferation is aﬀected by HMGA2 down-regulation. Cells from two hES cell lines (HUES-7 and HUES-8) were seeded at day 0.
Twenty-four hours later (day 1), cells were transfected with siRNA. This was repeated in 24 h intervals (days 2 and 3). WST-1 was added to the media
and absorbance (440 nm) was recorded each day, using media as reference. The assay was performed in triplicates with transfected (nt)-siRNA as
control.
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[21]. Hence, it is possible that HMGA2’s role in adipogenesis
includes that of a repressor of DLK1 expression. Other genes
in the top 10 list (Table 1) play roles in the formation of con-
nective tissue (COL6A2, COL16A1), as transcriptional repres-
sor during cell diﬀerentiation (NPM1), gap junction formation
(GAJ1), and trophoblast diﬀerentiation (CALB1).
Our microarray analysis is largely consistent with our qRT-
PCR data. Two genes, IGF2 and NESTIN, which showed dif-
ferential expression based on the qRT-PCR analysis (Fig. 2)
did not appear in our list of selected genes. In the case of
IGF2, the array signals were inconclusive and ﬂagged. NES-
TIN also appeared down-regulated in the microarray analysis
(0.81 fold change) consistent with the qRT-PCR data. How-
ever, it ranked at position 30 in the list due to its corrected
P-value of 0.16. Interestingly, the prominent pluripotency
markers Oct3/4 and Sox2 appear at positions 7 and 14, respec-
tively, in our list and are down-regulated (0.76 fold change).
While our qRT-PCR analysis also revealed a slight decrease
in expression level, it was found not to be statistically signiﬁ-
cant (Fig. 2). Hence, whether HMGA2 is directly involved in
the down-regulation of these two genes or whether this is an
indirect eﬀect perhaps due to the induction of cell diﬀerentia-
tion remains to be investigated.
3.4. HMGA2 regulates hES cell proliferation
Our results showed that HMGA2 is involved in the regula-
tion of UTF1 (Fig. 2) which is known to be critical for ES cell
proliferation in the mouse [17]. It has also been demonstratedthat mouse embryonic ﬁbroblasts derived from HMGA2 null
mice exhibit a signiﬁcantly slower proliferation rate than
wild-type cells [2]. Therefore, in order to analyze cell prolifer-
ation directly in hES cells, we employed again siRNA technol-
ogy, two hES cell lines (HUES-7 and HUES-8), and a
colorimetric assay which is based on the cleavage of the tetra-
zolium salt WST-1 to formazan by mitochondrial dehydrogen-
ases present in viable cells. We transfected hES cells with
siRNA as before over a period of three days and measured cell
proliferation using nt-siRNA as control. The results (Fig. 3)
show that after three days of repeated exposure to siRNA, cell
proliferation in both cell lines was signiﬁcantly reduced com-
pared with the control. Using again qRT-PCR (Fig. 2), we
conﬁrmed that mRNA levels of both HMGA2 and UTF1 were
reduced due to siRNA treatment (data not shown).
In summary, our data identify HMGA2 as regulator of
genes linked to mesenchymal cell diﬀerentiation, adipogenesis,
and cell proliferation in hES cells. They provide the basis for
further studies elucidating the molecular mechanisms how
these genes are regulated by HMGA2 in pluripotent hES cells,
and also during the early stages of human development
ex vivo. Furthermore, a better understanding of HMGA2’s
role in gene regulation may ultimately allow us to direct diﬀer-
entiation of hES cells into particular cell lineages by control-
ling HMGA2 protein levels.
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